Weight Loss Drug Misuse
-
{
- All
- News
- Videos
-
Is Erectile Dysfunction A Side Effect Of Taking Weight-Loss Drugs? New Trial Results Say Yes
- Friday April 17, 2026
- Health | Written by Shreya Goswami
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
-
www.ndtv.com
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
- Monday April 6, 2026
- Health | Written by Debosmita Ghosh
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
www.ndtv.com
-
With Rs 13,000-25,000 Per Dose, Weight-Loss Drugs Are Changing Indian Weddings For Brides
- Friday April 3, 2026
- Lifestyle | Reuters
The lowest Mounjaro injection pen dose sells for Rs 13,125 per month, while the highest dose costs Rs 25,781. Novo is selling the lowest Wegovy dose for Rs 5,660 and the highest for Rs 16,400 a month
-
www.ndtv.com/lifestyle
-
Weight-Loss Drug Misuse Under Scanner, Centre Warns Of Legal Action For Violations
- Wednesday April 1, 2026
- Health | Reported by Tanushka Dutta
The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but are increasingly being accessed without proper prescriptions through retail and digital channels.
-
www.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
- Tuesday March 24, 2026
- Health | Reported by Tanushka Dutta
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
www.ndtv.com
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
- Wednesday March 11, 2026
- Health | Reported by Tanushka Dutta, Edited by Shreya Goswami
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
www.ndtv.com
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
- Thursday March 5, 2026
- Health | Written by Shreya Goswami
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
Is Erectile Dysfunction A Side Effect Of Taking Weight-Loss Drugs? New Trial Results Say Yes
- Friday April 17, 2026
- Health | Written by Shreya Goswami
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
-
www.ndtv.com
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
- Monday April 6, 2026
- Health | Written by Debosmita Ghosh
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
www.ndtv.com
-
With Rs 13,000-25,000 Per Dose, Weight-Loss Drugs Are Changing Indian Weddings For Brides
- Friday April 3, 2026
- Lifestyle | Reuters
The lowest Mounjaro injection pen dose sells for Rs 13,125 per month, while the highest dose costs Rs 25,781. Novo is selling the lowest Wegovy dose for Rs 5,660 and the highest for Rs 16,400 a month
-
www.ndtv.com/lifestyle
-
Weight-Loss Drug Misuse Under Scanner, Centre Warns Of Legal Action For Violations
- Wednesday April 1, 2026
- Health | Reported by Tanushka Dutta
The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but are increasingly being accessed without proper prescriptions through retail and digital channels.
-
www.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
- Tuesday March 24, 2026
- Health | Reported by Tanushka Dutta
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
www.ndtv.com
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
- Wednesday March 11, 2026
- Health | Reported by Tanushka Dutta, Edited by Shreya Goswami
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
www.ndtv.com
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
- Thursday March 5, 2026
- Health | Written by Shreya Goswami
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com